3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Thrombocytopenia
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Interventions
Cyclophosphamide
45
fludarabine phosphate
39
Peripheral Blood Stem Cell Transplantation
36
Busulfan
34
Antilymphocyte Serum
26
Tacrolimus
25
Cyclosporine
25
Methotrexate
23
Filgrastim
23
Mycophenolic Acid
22
Radiotherapy
21
Melphalan
17
Etoposide
15
Cytarabine
15
Whole-Body Irradiation
14
Methylprednisolone
13
Cord Blood Stem Cell Transplantation
12
Biopsy
9
Azacitidine
9
Specimen Handling
8
ruxolitinib
7
Sirolimus
7
Flow Cytometry
7
Cyclosporins
7
Alemtuzumab
7
Thiotepa
6
Psychiatric Rehabilitation
6
Decitabine
6
sargramostim
5
Rituximab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Myelodysplastic-Myeloproliferative Diseases
×
Tranexamic Acid
×
Myeloid
×
Clear all
NCT06599762
2026-04-22
MYELO-CAN:TXA
University of Manitoba
Phase 2
Recruiting
75 enrolled